![]() |
市场调查报告书
商品编码
1665266
电切镜设备市场机会、成长动力、产业趋势分析与 2025 - 2034 年预测Resectoscope Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
2024 年全球电切镜设备市场价值为 4.022 亿美元,预计 2025 年至 2034 年期间将以 5.7% 的强劲复合年增长率增长。外科技术和技巧的不断进步进一步推动了全球医疗机构采用电切镜设备。
根据类型,市场分为单极、双极和混合电切镜。单极电切镜预计将实现显着增长,预计复合年增长率为 5.5%,到 2034 年市场价值将达到 3.273 亿美元。与双极系统相比,它们的经济实惠使其成为已开发地区和新兴地区医疗保健提供者的有吸引力的选择,确保了它们在未来几年内持续占据市场主导地位。
市场范围 | |
---|---|
起始年份 | 2024 |
预测年份 | 2025-2034 |
起始值 | 4.022亿美元 |
预测值 | 6.944 亿美元 |
复合年增长率 | 5.7% |
市场还根据最终用途进行细分,包括医院、诊所、门诊手术中心和其他医疗保健提供者。 2024 年,医院凭藉其先进的手术基础设施和尖端成像技术的集成,占据了 45.6% 的市场份额。泌尿科医生和妇科医生等专业人员的存在确保了手术过程的精确性和安全性,巩固了医院作为电切镜设备应用的首选地位。他们处理复杂和微创手术的能力进一步增强了他们在市场上的地位。
在美国,2024 年电切镜设备市场价值为 1.487 亿美元,预计到 2034 年复合年增长率为 4.9%。此外,医疗支出增加、老龄人口成长以及微创手术需求增加等因素也推动了美国市场的持续成长
The Global Resectoscope Devices Market, valued at USD 402.2 million in 2024, is anticipated to grow at a robust CAGR of 5.7% between 2025 and 2034. This growth is driven by the rising prevalence of urological and gynecological conditions and an increasing preference for minimally invasive surgical procedures. Continued advancements in surgical technologies and techniques are further propelling the adoption of resectoscope devices in healthcare facilities worldwide.
By type, the market is segmented into monopolar, bipolar, and hybrid resectoscopes. Monopolar resectoscopes are expected to see significant growth, with a projected CAGR of 5.5%, reaching a market value of USD 327.3 million by 2034. These devices are widely favored for their efficiency and cost-effectiveness, particularly in transurethral and gynecological surgeries. Their affordability compared to bipolar systems makes them an attractive option for healthcare providers in both developed and emerging regions, ensuring their sustained market dominance over the coming years.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $402.2 Million |
Forecast Value | $694.4 Million |
CAGR | 5.7% |
The market is also segmented by end use, including hospitals, clinics, ambulatory surgical centers, and other healthcare providers. Hospitals accounted for a leading 45.6% share of the market in 2024, bolstered by their advanced surgical infrastructure and integration of cutting-edge imaging technologies. The presence of specialized professionals such as urologists and gynecologists ensures precision and safety during procedures, solidifying hospitals as the top choice for resectoscope device applications. Their ability to handle both complex and minimally invasive surgeries further enhances their position in the market.
In the United States, the resectoscope devices market was valued at USD 148.7 million in 2024, with a projected CAGR of 4.9% through 2034. The country's well-established healthcare infrastructure, widespread adoption of advanced surgical equipment, and the presence of key market players are driving its dominance. Additionally, factors such as increased healthcare spending, a growing elderly population, and rising demand for minimally invasive surgeries contribute to sustained market growth in the U.S.